Molecular Immunology

Molecular Immunology 由 Elsevier Ltd 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Monoclonal and Polyclonal Antibodies Research、T-cell and B-cell Immunology、Complement system in diseases 等主题的论文，这 3 个主题约占 35.4%，主导子领域为 Immunology。（根据 OpenAlex 主题统计与中科院分区数据生成）

Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunologyMechanisms of induction, regulation and termination of innate and adaptive immunityIntercellular communication, cooperation and regulationIntracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)Mechanisms of action of the cells and molecules of the immune systemStructural analysisDevelopment of the immune systemComparative immunology and evolution of the immune system"Omics" studies and bioinformaticsVaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)Technical developmentsArticles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.Clinical studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-免疫学

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

3.65LetPub · 2026-09-13

影响因子（出版商公布）

3.7出版商官网 · 2026-09-29

CiteScore 2026-06

6.1LetPub · 2026-09-13

CiteScore（出版商公布）

6.1出版商官网 · 2026-09-29

SJR 2026-06

0.97LetPub · 2026-09-13

SNIP 2026-06

0.77LetPub · 2026-09-13

h-index

113LetPub · 2026-09-13

h-index

182OpenAlex · 2026-10-01

i10-index

6,772OpenAlex · 2026-10-01

两年平均被引

3.12OpenAlex · 2026-10-01

自引率

2.7%LetPub · 2026-09-13

Gold OA 文章占比

25.61%LetPub · 2026-09-13

发文规模

年文章数

198LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

平均2.0个月来源Elsevier官网：平均7.2周LetPub · 2026-09-13

平均录用比例（社区反馈）

62.5%LetPub · 2026-09-13

投稿到首次决定

2 天出版商官网 · 2026-09-29

外审后首次决定

41 天出版商官网 · 2026-09-29

投稿到接收

96 天出版商官网 · 2026-09-29

接收到发表

8 天出版商官网 · 2026-09-29

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Elsevier Ltd

出版国家或地区

ENGLAND

出版语言

Multi-Language

出版周期

Semimonthly

创刊年份

1979

ISSN

0161-5890

电子版 ISSN

1872-9142

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网